Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5614606 | Journal of Cardiology | 2017 | 7 Pages |
Abstract
We identified risk factors associated with an increased risk of giant CAA. The difference in variables between the giant CAA group and the other CAA subgroups suggests a separation between patients with the treatment-resistant giant CAA and the other IVIG-responsive patients, in which gender may be factored as a most relevant genetic trait. The increase in size during the first 2 months indicates the need for repeated echocardiography.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sanne M. MD, Irene M. MD, PhD, Carline E.A. MD, PhD, Jeffrey C.D. BSc, Barbara A. MSc, PhD, Taco W. MD, PhD,